Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP893456.RAqF-eCSeYmRD9Q0DT1QWSVxQru0wHPr2yMNMQqTRJH78130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP893456.RAqF-eCSeYmRD9Q0DT1QWSVxQru0wHPr2yMNMQqTRJH78130_assertion type Assertion NP893456.RAqF-eCSeYmRD9Q0DT1QWSVxQru0wHPr2yMNMQqTRJH78130_head.
- NP893456.RAqF-eCSeYmRD9Q0DT1QWSVxQru0wHPr2yMNMQqTRJH78130_assertion description "[These results strongly support the utilization of PI3K pathway inhibitors in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893456.RAqF-eCSeYmRD9Q0DT1QWSVxQru0wHPr2yMNMQqTRJH78130_provenance.
- NP893456.RAqF-eCSeYmRD9Q0DT1QWSVxQru0wHPr2yMNMQqTRJH78130_assertion evidence source_evidence_literature NP893456.RAqF-eCSeYmRD9Q0DT1QWSVxQru0wHPr2yMNMQqTRJH78130_provenance.
- NP893456.RAqF-eCSeYmRD9Q0DT1QWSVxQru0wHPr2yMNMQqTRJH78130_assertion SIO_000772 21563232 NP893456.RAqF-eCSeYmRD9Q0DT1QWSVxQru0wHPr2yMNMQqTRJH78130_provenance.
- NP893456.RAqF-eCSeYmRD9Q0DT1QWSVxQru0wHPr2yMNMQqTRJH78130_assertion wasDerivedFrom befree-2016 NP893456.RAqF-eCSeYmRD9Q0DT1QWSVxQru0wHPr2yMNMQqTRJH78130_provenance.
- NP893456.RAqF-eCSeYmRD9Q0DT1QWSVxQru0wHPr2yMNMQqTRJH78130_assertion wasGeneratedBy ECO_0000203 NP893456.RAqF-eCSeYmRD9Q0DT1QWSVxQru0wHPr2yMNMQqTRJH78130_provenance.